Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
12299237 | Pharmaceutical composition | A61K | May 1, 2007 | Jul 17, 2017 |
12299880 | Process for the preparation of pure irbesartan | C07D, A61K | Apr 3, 2007 | Jul 2, 2012 |
12294571 | Coated formulations for tolterodine | A61P, C08L, A61K | Mar 28, 2007 | Feb 3, 2014 |
12223493 | Pharmaceutical Composition Comprising Perindopril | C07H, A61K | Jan 30, 2007 | Jul 24, 2012 |
12159409 | HETEROCYCLIC COMPOUNDS | C07D, A61K | Dec 26, 2006 | Sep 29, 2011 |
12086657 | Bursting Pellets | A61K, A61P | Dec 20, 2006 | Oct 16, 2012 |
12158413 | Pharmaceutical composition | A61K, A61P | Dec 17, 2006 | Jan 22, 2017 |
12093974 | Use of Aza-Phenylalanine Compounds For Treating Cardiac Arrhythmia | A61P, A61K | Nov 15, 2006 | Aug 1, 2013 |
12088019 | Process for the synthesis of HMG-CoA reductase inhibitors | C07D | Oct 3, 2006 | Sep 17, 2012 |
11992212 | Novel Process | C07D | Sep 18, 2006 | May 28, 2013 |
11991201 | Pharmaceutical Composition Comprising Perindopril or Its Salts | A61K | Aug 27, 2006 | Sep 11, 2011 |
12063493 | PROCESS FOR THE PREPARATION OF PERINDOPRIL ERBUMINE | C07D | Aug 9, 2006 | Sep 30, 2010 |
11997070 | Process for the synthesis of rosuvastatin calcium | C07D, A61K | Jul 25, 2006 | Jan 14, 2013 |
11996438 | Process for the preparation of crystalline perindopril | A61K, A61P, C07D | Jul 23, 2006 | Apr 11, 2011 |
11922532 | Process for preparing amorphous rosuvastatin calcium of impurities | C07D, A61P, A61K | Jun 21, 2006 | Oct 5, 2015 |
11916599 | Process for preparing pure amorphous rosuvastatin calcuim | A61K, C07D | Jun 21, 2006 | Jun 25, 2012 |
11916462 | Crystalline solvate of omeprazole sodium | C07D, A61K | Jun 6, 2006 | Aug 20, 2012 |
11920870 | Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl) Methyl)-imidazole, dihydroimidazole or benzimidazloe derivatives | A61K, C07D | May 21, 2006 | Jun 13, 2012 |
11887637 | Synthesis of 4-bromomethyl-2′-formylbiphenyl and 4-bromomethyl-2′-hydroxymethylbiphenyl and its use in preparation of angiotensin II antagonists | C07C, C07D, A61K | Mar 29, 2006 | Jun 27, 2011 |
11795920 | Pharmaceutical Composition Containing Candesartan Cilexetil as Lipophilic Crystalline Substance | A61K | Jan 23, 2006 | Jan 13, 2014 |